Trends in breast cancer screening during the COVID‐19 pandemic within a universally insured health system in the United States, 2017–2022
Abstract
In the United States, breast cancer is the most commonly diagnosed cancer and second leading cause of cancer death in women. Early detection through mammogram screening is instrumental in reducing mortality and incidence of disease. The COVID‐19 pandemic posed unprecedented challenges to the provision of care, including delays in preventive screenings. We examined trends in breast cancer screening during the COVID‐19 pandemic in a universally insured national population and evaluated rates across racial groups and socioeconomic strata.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 28, 2023
- Source ID
- 10.1002/cam4.6487
Entities
People
- Ada Umoh
- Amanda Banaag
- Andrew J. Schoenfeld
- Christian L. Coles
- Satish Munigala
- Tracey Perez Koehlmoos
- Vivitha Mani
Organizations
- Defense Health Agency
- Harvard Medical School
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Uniformed Services University of the Health Sciences